BioNexus Gene Lab Corp. (BGLC) vs Iveda Solutions, Inc. (IVDA)
A side-by-side comparison of BioNexus Gene Lab Corp. and Iveda Solutions, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BGLC
BioNexus Gene Lab Corp.
$1.21IndustrialsDelayed quote: Oct 6, 2026, 11:54 AM EDT
IVDA
Iveda Solutions, Inc.
$0.29IndustrialsDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — BGLC vs IVDA
growth of $100 · dividends reinvested · last 6yBGLC -99.5% (-58.9%/yr)IVDA -99.1% (-54.1%/yr)IVDA compounded faster over this window
BGLC IVDA
BGLC vs IVDA: by the numbers
- •IVDA is the larger company ($3M vs $3M market cap).
- •Both run net losses; IVDA's is the smaller (-69.24% vs -82.36% net margin).
- •IVDA grew revenue faster over the past five years (26.91% vs -31.68% CAGR).
Metrics side by side
Valuation
| Metric | BGLC | IVDA |
|---|---|---|
| P/S ratio | 0.94 | 0.73 |
| P/B ratio | 0.38 | 0.62 |
Profitability
| Metric | BGLC | IVDA |
|---|---|---|
| Gross margin | 11.64% | 24.11% |
| Operating margin | -42.54% | -68.54% |
| Net margin | -82.36% | -69.24% |
| ROE | -33.11% | -58.56% |
| ROIC | -32.71% | -51.05% |
Growth (annualized)
| Metric | BGLC | IVDA |
|---|---|---|
| Revenue CAGR (5Y) | -31.68% | 26.91% |
| Total return CAGR (5Y) | -61.00% | -65.37% |
Frequently asked
- Which has grown faster, BGLC or IVDA?
- Over the past five years, IVDA grew revenue faster — BGLC at a -31.68% CAGR versus IVDA at 26.91%.
- How have BGLC and IVDA total returns compared?
- Over the past 5 years, BGLC delivered -61.00% and IVDA delivered -65.37% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
BioNexus Gene Lab ROEIveda Solutions ROEBioNexus Gene Lab operating marginIveda Solutions operating marginBioNexus Gene Lab revenue growthIveda Solutions revenue growthBioNexus Gene Lab free cash flowIveda Solutions free cash flow
BioNexus Gene Lab & Iveda Solutions appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.